Listen to the discussion on contamination risks in biomanufacturing, featuring mycoplasma and virus testing per European Pharmacopoeia and USP standard.
Contamination in biological production can pose safety risks. Biopharmaceutical manufacturers must identify contamination sources, especially in cell and gene therapies, to reduce risks and avoid costly recalls.
Join our experts discuss tracking contaminants in biomanufacturing as per European Pharmacopoeia and USP standards. They will review contamination risks, mycoplasma testing (rapid and culture methods), and adventitious virus testing using molecular and virology methods.
